Global Point of Care Diagnostics Market Overview:
Global Point of Care Diagnostics Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2024 as the base year.
Global Point of Care Diagnostics Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Point of Care Diagnostics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Point of Care Diagnostics Market:
The Point of Care Diagnostics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Point of Care Diagnostics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Point of Care Diagnostics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Point of Care Diagnostics market has been segmented into:
Lateral Flow
Agglutination Assays
Flow-Through
Solid Phase
Biosensors
By Application, Point of Care Diagnostics market has been segmented into:
Cardio Metabolic Testing
Infectious Disease Testing
Nephrology Testing
Drugs of Abuse (DoA
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Point of Care Diagnostics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Point of Care Diagnostics market.
Top Key Players Covered in Point of Care Diagnostics market are:
F. Hoffmann-La Roche Ltd
Abbott Laboratories
Siemens Healthineers AG
Becton
Dickinson and Company
Qiagen Inc.
Johnson & Johnson Servicesinc.
Danaher Corporation (Beckman Coulter Inc.)
Instrumentation Laboratory
Nova Biomedical Corporation
Biomeriux SA
GE Healthcare
Philips Healthcare
Quest Diagnostics
Fujifilm Medical
Thermo Fisher Scientific
Hologic
Canon
IDEXX Laboratories
Sysmex
QuidelOrtho
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Point of Care Diagnostics Market by Type
4.1 Point of Care Diagnostics Market Snapshot and Growth Engine
4.2 Point of Care Diagnostics Market Overview
4.3 Lateral Flow
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Lateral Flow: Geographic Segmentation Analysis
4.4 Agglutination Assays
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Agglutination Assays: Geographic Segmentation Analysis
4.5 Flow-Through
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Flow-Through: Geographic Segmentation Analysis
4.6 Solid Phase
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Solid Phase: Geographic Segmentation Analysis
4.7 Biosensors
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Biosensors: Geographic Segmentation Analysis
Chapter 5: Point of Care Diagnostics Market by Application
5.1 Point of Care Diagnostics Market Snapshot and Growth Engine
5.2 Point of Care Diagnostics Market Overview
5.3 Cardio Metabolic Testing
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Cardio Metabolic Testing: Geographic Segmentation Analysis
5.4 Infectious Disease Testing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Infectious Disease Testing: Geographic Segmentation Analysis
5.5 Nephrology Testing
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Nephrology Testing: Geographic Segmentation Analysis
5.6 Drugs of Abuse (DoA
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Drugs of Abuse (DoA: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Point of Care Diagnostics Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 F. HOFFMANN-LA ROCHE LTD
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 ABBOTT LABORATORIES
6.4 SIEMENS HEALTHINEERS AG
6.5 BECTON
6.6 DICKINSON AND COMPANY
6.7 QIAGEN INC.
6.8 JOHNSON & JOHNSON SERVICESINC.
6.9 DANAHER CORPORATION (BECKMAN COULTER INC.)
6.10 INSTRUMENTATION LABORATORY
6.11 NOVA BIOMEDICAL CORPORATION
6.12 BIOMERIUX SA
6.13 GE HEALTHCARE
6.14 PHILIPS HEALTHCARE
6.15 QUEST DIAGNOSTICS
6.16 FUJIFILM MEDICAL
6.17 THERMO FISHER SCIENTIFIC
6.18 HOLOGIC
6.19 CANON
6.20 IDEXX LABORATORIES
6.21 SYSMEX
6.22 QUIDELORTHO
Chapter 7: Global Point of Care Diagnostics Market By Region
7.1 Overview
7.2. North America Point of Care Diagnostics Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Lateral Flow
7.2.4.2 Agglutination Assays
7.2.4.3 Flow-Through
7.2.4.4 Solid Phase
7.2.4.5 Biosensors
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Cardio Metabolic Testing
7.2.5.2 Infectious Disease Testing
7.2.5.3 Nephrology Testing
7.2.5.4 Drugs of Abuse (DoA
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Point of Care Diagnostics Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Lateral Flow
7.3.4.2 Agglutination Assays
7.3.4.3 Flow-Through
7.3.4.4 Solid Phase
7.3.4.5 Biosensors
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Cardio Metabolic Testing
7.3.5.2 Infectious Disease Testing
7.3.5.3 Nephrology Testing
7.3.5.4 Drugs of Abuse (DoA
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Point of Care Diagnostics Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Lateral Flow
7.4.4.2 Agglutination Assays
7.4.4.3 Flow-Through
7.4.4.4 Solid Phase
7.4.4.5 Biosensors
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Cardio Metabolic Testing
7.4.5.2 Infectious Disease Testing
7.4.5.3 Nephrology Testing
7.4.5.4 Drugs of Abuse (DoA
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Point of Care Diagnostics Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Lateral Flow
7.5.4.2 Agglutination Assays
7.5.4.3 Flow-Through
7.5.4.4 Solid Phase
7.5.4.5 Biosensors
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Cardio Metabolic Testing
7.5.5.2 Infectious Disease Testing
7.5.5.3 Nephrology Testing
7.5.5.4 Drugs of Abuse (DoA
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Point of Care Diagnostics Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Lateral Flow
7.6.4.2 Agglutination Assays
7.6.4.3 Flow-Through
7.6.4.4 Solid Phase
7.6.4.5 Biosensors
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Cardio Metabolic Testing
7.6.5.2 Infectious Disease Testing
7.6.5.3 Nephrology Testing
7.6.5.4 Drugs of Abuse (DoA
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Point of Care Diagnostics Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Lateral Flow
7.7.4.2 Agglutination Assays
7.7.4.3 Flow-Through
7.7.4.4 Solid Phase
7.7.4.5 Biosensors
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Cardio Metabolic Testing
7.7.5.2 Infectious Disease Testing
7.7.5.3 Nephrology Testing
7.7.5.4 Drugs of Abuse (DoA
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Point of Care Diagnostics Scope:
|
Report Data
|
Point of Care Diagnostics Market
|
|
Point of Care Diagnostics Market Size in 2025
|
USD XX million
|
|
Point of Care Diagnostics CAGR 2025 - 2032
|
XX%
|
|
Point of Care Diagnostics Base Year
|
2024
|
|
Point of Care Diagnostics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
F. Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson and Company, Qiagen Inc., Johnson & Johnson Servicesinc., Danaher Corporation (Beckman Coulter Inc.), Instrumentation Laboratory, Nova Biomedical Corporation, Biomeriux SA, GE Healthcare, Philips Healthcare, Quest Diagnostics, Fujifilm Medical, Thermo Fisher Scientific, Hologic, Canon, IDEXX Laboratories, Sysmex, QuidelOrtho.
|
|
Key Segments
|
By Type
Lateral Flow
Agglutination Assays
Flow-Through
Solid Phase
Biosensors
By Applications
Cardio Metabolic Testing
Infectious Disease Testing
Nephrology Testing
Drugs of Abuse (DoA
|
